Drug boosts survival of relapsed multiple myeloma
Adding the drug lenalidomide, a less-toxic relative of the drug thalidomide, to standard dexamethasone therapy can improve survival in patients with relapsed or hard-to-treat multiple myeloma (cancer of the blood). More
Comments